Experimental Antidepressant Appears Quick-Ac... ( By Steven Reinberg HealthDay Rep...)

Experimental Antidepressant Appears Quick-Acting, Safe

Date:12/9/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, Dec. 7 (HealthDay News) -- An experimental antidepressant that targets the brain in a different way appears to both act fast and last long, researchers say.

The new drug -- called GLYX-13 -- is so far given in an intravenous form and was recently tested in patients who had not responded to other antidepressants. It began its work within hours and a single dose lasted about a week, Northwestern University researchers reported.

"We saw a robust, rapid-acting, long-lasting effect," said lead researcher Joseph Moskal, a research professor of biomedical engineering at Northwestern's McCormick School of Engineering and Applied Science and director of the school's Falk Center for Molecular Therapeutics. "In addition, we have shown little or no side effects with our compound."

One expert said the drug might prove a valuable tool against depression.

"It sounds like an exciting development," Dr. Bryan Bruno, acting chair of psychiatry at Lenox Hill Hospital in New York City said. If it were a pill, the drug could change treatment for many patients, he added. "Because it's so quick it would be a huge advantage over our current medications all of which take six to eight weeks for the full effect and at least three to four weeks to start working for most people," Bruno said.

Currently, the most popular drugs to treat depression are called selective serotonin reuptake inhibitors, or SSRIs. These include Prozac, Paxil, Zoloft and Lexapro. They work by improving levels of the hormone serotonin, which may be too low in people suffering from depression.

Although SSRIs are effective in many people, not all respond to the same drugs and some people don't respond well.

GLYX-13, the new drug, is still being studied and it isn't projected to be available before some time in 2016, Moskal said. Many unknowns remain about the drug, including its long-term effects, wh
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Experimental Chemo Combo for Colon Cancer Disappoints
2. Experimental Pill for Multiple Sclerosis Shows Promise
3. Experimental Gel May Help Those With Advanced Parkinsons
4. Experimental Drug Eases Autistic Behaviors in Mice
5. Experimental Drug Helps Fight Some Childhood Cancers, Study Finds
6. Experimental drug improves muscle strength among male cancer patients
7. Experimental Vaccine Seems to Stop Nicotine Addiction in Mice
8. Content Writing King Announces Cancellation Of Experimental Video Creation Process For Their Article Marketing Website
9. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
10. Experimental drug may extend therapeutic window for stroke
11. Experimental Chemical Helps Blind Mice See

Post Your Comments:

Related Image:

Experimental Antidepressant Appears Quick-Acting, Safe

(Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is on ... hours a week of applied behavior analysis (ABA) therapy ... Autism and Related Disorders (CARD). Riley has been in ... remarkable progress, including learning to speak, starting conversations, making ... through autism is now featured in CARD’s “Mission Possible: ...

(Date:6/18/2013)... have launched an innovative clinical trial, unique in ... a patient,s own stem cells to prevent leg ... , Led by Vik Kashyap, MD, Division ... Center,s Harrington Heart & Vascular Institute and Professor ... of Medicine, the clinical trial is designed to ...

(Date:6/18/2013)... More than 1.1 million people in the U.S. ages 13 ... for Disease Control and Prevention (CDC). Of those, nearly 20 ... HIV Testing Day on June 27, Allsup, a nationwide provider ... CDC and other organizations are raising awareness of the importance ... new HIV infections each year. Along with developing AIDS, those ...

(Date:6/18/2013)... June 18, 2013 myCNAjobs announces the ... free downloads, articles, and tips to the Caregiver Resources ... care for the 10,000+ retiring baby boomers each day, ... caregiver job resources has never been greater. ... job community, recently launched the first-ever free resource ...

(Date:6/18/2013)... FL (PRWEB) June 18, 2013 A ... by storm. The burgeoning aquaculture industry is redefining the ... one of the most acclaimed personal culinary chefs on ... clientele on benefits of sustainable seafood and the promising ... in abundance these days. Many consumers strive to fully ...

Breaking Medicine News(10 mins):Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3 Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2 Health News:New $119 Million Industry Swimming Up the East Coast 2

[0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation [0] Allsup Observes National HIV Testing Day June 27 [0] myCNAjobs Adds New Resources to Growing Caregiver Career Center [0] New $119 Million Industry Swimming Up the East Coast

... When family members ask physicians not to disclose bad ... balance their obligation to be truthful to the patient ... harmful. To help clinicians more successfully manage these conflicts, ... in collaboration with colleagues at Stanford University, have developed ...

... Ellex Medical Lasers,Limited (ASX: ELX), a global ... and ultrasound systems, announced today that the initial,results ... will be presented by Peter Hamilton MD, FRCOph ... Ophthalmology, which takes place,November 10-13, in New Orleans. ...

... Inc. announced,completion of the company,s Phase 1 clinical ... for the treatment of inflammatory,diseases linked to the ... Phase 1 trial for AM803, a second oral ... AM103 and AM803 are novel inhibitors of 5-lipoxygenase-activiting,protein ...

... tool for 50% faster miRNA preparation with no,detectable large RNA ... ... developing area of RNAi, ST. LOUIS, Nov. 1 ... Kit,( http://www.sigma.com/mirna ) for purification of miRNA from diverse,biological sources. ...

... - 20% U.S. Sequential Quarterly Sales Increase ... - FY08 Revenue Projection Raised - ... - Conference Call to be Held at 10:00 a.m. Central Time Today -, ... million for the second quarter,of fiscal 2008 ended September 30, 2007, up 73% from $1.8 ...

... Sales up 11.2% and Earnings Per Diluted Share up 20% Excluding Tax Items ... ... Fourth Quarter - - Conference ... West Pharmaceutical,Services, Inc. (NYSE: WST ) today announced the results of operations for,the ...

Don't tell mother she has cancer Ellex Announces New Retina Regeneration Therapy to be Presented at the AAO Amira Pharmaceuticals Announces Favorable Phase 1 Clinical Trial Results for Lead Product Candidate AM103 and Initiates Clinical Studies for the 2nd Entry Molecule for the Treatment of Respiratory and Cardiovascular Disease Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification Uroplasty, Inc. Reports Record Sales For Second Fiscal Quarter West Pharmaceutical Services Announces Third Quarter 2007 Results

(Date:6/18/2013)... , June 18, 2013 Decision Resources, ... firms for pharmaceutical and healthcare issues, announces that ... of the Middle East ... Tracker analyzes the challenges and opportunities to gaining ... international regions comprising 24 countries. The countries covered ...

(Date:6/18/2013)... , June 18, 2013 Today, ... Inc. (NASDAQ: GILD ), Health Management Associates Inc. ... IDXX ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ... access these reports free of charge - including full price ... below. Gilead Sciences, Inc. Research Report ...

(Date:6/18/2013)... Pro football player and 2012 most valuable player ... Jo Frost have potentially life-threatening (severe) allergies ... integrated specialty pharmaceutical business of Mylan Inc. (Nasdaq: ... health problem. In recognition of the 25 th ... approval of EpiPen ® (epinephrine) Auto-Injector, ...

Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2 Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6 Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 2 Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 3 Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 4 Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 5 Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 6 Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 7 Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign 8

[0] Decision Resources' Market Access Tracker Now Covers the Middle East and Africa [0] Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics [0] Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign

... 16, 2011 SmallCapVoice.com, Inc. announced today ... Home Medical Equipment, Inc. (Pinksheets: SHOM), a ... and durable medical equipment to medical institutions, ... heard at http://smallcapvoice.com/blog/6-14-11-audio-interview-with-southern-home-medical-equipment-inc-pink-sheets-shom . ...

... Omnicell, Inc . (NASDAQ: OMCL ), ... and analytics software for healthcare facilities, today announced the ... ® automated dispensing system as the recipient of its ... Units for large hospitals with more than 200 beds ...

Cached Medicine Technology:A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 2 A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com 3 Omnicell's OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award 2 Omnicell's OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award 3 Omnicell's OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award 4

A New Audio Interview With Jerry Overcash, Director for Southern Home Medical Equipment, Inc., is now at SmallCapVoice.com Omnicell's OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award

... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...

... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...

... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...

... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...

Medicine Products:

Immunoglobulin G, CSF Immunoglobulin A, CSF Immunofixation Electrophoresis Gel Immunocytochemistry